Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Hepatology (Baltimore, Md.)
|
February 1, 1993
The self-sustained sequence replication amplification system--move over, PCR
K S Lown
Hepatology (Baltimore, Md.)
|
August 1, 1991
Predicting drug interactions using cultured human hepatocytes
K S Lown, P B Watkins
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 28, 1998
Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical
K S Lown, M Ghosh, P B Watkins
Pharmacogenetics
|
October 1, 1996
Selective expression of CYP3A5 and not CYP3A4 in human blood
S K Janardan, K S Lown, P Schmiedlin-Ren, et al.
Molecular Pharmacology
|
May 1, 1997
Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3
P Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1995
The erythromycin breath test predicts the clearance of midazolam
K S Lown, K E Thummel, P E Benedict, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1994
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test
K S Lown, J C Kolars, K E Thummel, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1994
P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients
D K Turgeon, A B Leichtman, K S Lown, et al.
Transplantation
|
June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients
D K Turgeon, A B Leichtman, D S Blake, et al.
Pharmacogenetics
|
October 1, 1994
CYP3A gene expression in human gut epithelium
J C Kolars, K S Lown, P Schmiedlin-Ren, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Hepatology (Baltimore, Md.)
|
February 1, 1993
The self-sustained sequence replication amplification system--move over, PCR
K S Lown
Hepatology (Baltimore, Md.)
|
August 1, 1991
Predicting drug interactions using cultured human hepatocytes
K S Lown, P B Watkins
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 28, 1998
Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical
K S Lown, M Ghosh, P B Watkins
Pharmacogenetics
|
October 1, 1996
Selective expression of CYP3A5 and not CYP3A4 in human blood
S K Janardan, K S Lown, P Schmiedlin-Ren, et al.
Molecular Pharmacology
|
May 1, 1997
Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3
P Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1995
The erythromycin breath test predicts the clearance of midazolam
K S Lown, K E Thummel, P E Benedict, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1994
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test
K S Lown, J C Kolars, K E Thummel, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1994
P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients
D K Turgeon, A B Leichtman, K S Lown, et al.
Transplantation
|
June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients
D K Turgeon, A B Leichtman, D S Blake, et al.
Pharmacogenetics
|
October 1, 1994
CYP3A gene expression in human gut epithelium
J C Kolars, K S Lown, P Schmiedlin-Ren, et al.
Page
of 2